The Blood Service’s scientific research is guided by the focus areas specified in the research strategy:
• Blood supply chain efficiency
• Effectiveness of cell therapies and transplantations
Development work on new cell therapy products has accelerated, thanks to a cooperation agreement with the University of Helsinki and Helsinki University Hospital. Several new cell therapy products are being developed in our Cell Production Centre. We were also chosen to coordinate an extensive project funded by Business Finland. One of its aims is to test whether blood products can be developed to act as new drug carriers.
Our Biobank has received consent from over 50,000 blood donors for their blood samples to be used in research projects by the Blood Service and other parties.
The total costs of our research and development operations were about €3.2 million, 61% of which was covered by external funding. In 2020, two doctoral theses on cell therapy and one doctoral thesis on tissue compatibility were completed within the Blood Service.
In spring 2020, our R&D department was transferred to the Biomedicum campus in the Meilahti hospital area, which will strengthen the visibility of R&D as well as cooperation with other research groups on the campus.